Vision Biosciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 Cr
as on 13-12-2024
- Revenue %
(FY 2022)
- Net Worth 763.76%
(FY 2022)
- Total Assets 23477.38%
(FY 2022)
About Vision Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 Cr.
Shilpa Phadnis, Ravikant Rayanade, and Santosh Dakare serve as directors at the Company.
- CIN/LLPIN
U74999PN2016PTC166440
- Company No.
166440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vision Biosciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravikant Rayanade  | Director | 11-Oct-2021 | Current |
| Shilpa Phadnis | Director | 04-Nov-2016 | Current |
| Santosh Dakare | Director | 10-Feb-2021 | Current |
Financial Performance of Vision Biosciences.
Vision Biosciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 763.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vision Biosciences?
In 2022, Vision Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Precise Uzind Pharmaceuticals Private LimitedActive 4 years 7 monthsShilpa Phadnis is a mutual person
- Kolhapur Construction Corporation Private LimitedActive 10 years 10 months
Shilpa Phadnis is a mutual person
- Midastouch Market Research Analysts Private LimitedActive 3 years 7 months
Shilpa Phadnis is a mutual person
- Visionario Life Sciences Private LimitedActive 9 years 5 months
Shilpa Phadnis and Ravikant Rayanade are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2022 | ₹2.50 Cr | Open |
How Many Employees Work at Vision Biosciences?
Unlock and access historical data on people associated with Vision Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vision Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vision Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
